Dr. Garrard is Chief Safety Officer for Drug Safety Alliance, Inc. She provides leadership in strategic planning, analysis, development, implementation and measurement of all aspects of drug safety and medical services including signal management and risk evaluation and mitigation strategy.
Dr. Fiore is a board certified medical doctor and has been responsible for many areas of drug safety, including operations, outsourcing, medical, etc. He is also experienced in development having been responsible for a Phase II program. Dr. Fiore is currently a consultant in PV.
Dr. Michael Ibara is Head of Pharmacovigilance Information Mgt at Pfizer. His current focus is on pharmacovigilance, digital healthcare, eHealth and the possibility of improving public health through innovative approaches to pharmacovigilance.
Description
This session will focus on the specific types of social media currently being used by pharmaceutical companies with discussion on their successes and challenges. In addition, discussions on AE identification and collection while emphasizing the need for practices and guidance on the use of social media.
Learning Objectives: Describe how pharmaceutical companies are currently using social media Define the challenges of social media used by the pharmaceutical companies industry Explain how Adverse Events are being detected in social media and who is responsible for these Adverse Events Identify good social media practices.